These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. Greer GR; Grob CS; Halberstadt AL J Psychoactive Drugs; 2014; 46(1):73-7. PubMed ID: 24830188 [TBL] [Abstract][Full Text] [Related]
4. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. Hill MN; Campolongo P; Yehuda R; Patel S Neuropsychopharmacology; 2018 Jan; 43(1):80-102. PubMed ID: 28745306 [TBL] [Abstract][Full Text] [Related]
5. Achieving independence for advanced practice registered nurses in Connecticut. Shea JM Clin Nurse Spec; 2015; 29(2):112-4. PubMed ID: 25654711 [No Abstract] [Full Text] [Related]
6. The 28th Annual APRN Legislative Update: Beyond the 50 states. Newland J Nurse Pract; 2016 Jan; 41(1):8. PubMed ID: 26678419 [No Abstract] [Full Text] [Related]
7. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833 [TBL] [Abstract][Full Text] [Related]
8. APRNs' controlled substance prescribing and readiness following Florida legislative changes. Reynolds AM; Reynolds CJ; Craig-Rodriguez A Nurse Pract; 2021 Jun; 46(6):48-55. PubMed ID: 34004642 [TBL] [Abstract][Full Text] [Related]
9. Cannabis: A potential efficacious intervention for PTSD or simply snake oil? Abizaid A; Merali Z; Anisman H J Psychiatry Neurosci; 2019 Mar; 44(2):75-78. PubMed ID: 30810022 [No Abstract] [Full Text] [Related]
10. 30th Annual APRN Legislative Update: Improving access to healthcare one state at a time. Phillips SJ Nurse Pract; 2018 Jan; 43(1):27-54. PubMed ID: 29240621 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoids: Medical implications. Schrot RJ; Hubbard JR Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385 [TBL] [Abstract][Full Text] [Related]
13. Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder. Neumeister A; Seidel J; Ragen BJ; Pietrzak RH Psychoneuroendocrinology; 2015 Jan; 51():577-84. PubMed ID: 25456347 [TBL] [Abstract][Full Text] [Related]
14. [Nurse prescribing, a step away from being legal]. González Sánchez J Gac Sanit; 2015; 29(6):472. PubMed ID: 26253338 [No Abstract] [Full Text] [Related]
15. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. Steenkamp MM; Blessing EM; Galatzer-Levy IR; Hollahan LC; Anderson WT Depress Anxiety; 2017 Mar; 34(3):207-216. PubMed ID: 28245077 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders. Cohen J; Wei Z; Phang J; Laprairie RB; Zhang Y J Clin Neurophysiol; 2020 Jan; 37(1):28-34. PubMed ID: 31895187 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder. Ney LJ; Matthews A; Bruno R; Felmingham KL Neurosci Biobehav Rev; 2018 Nov; 94():302-320. PubMed ID: 30017748 [TBL] [Abstract][Full Text] [Related]
18. Policy brief tackles scope of practice laws and their impact. Nurse Pract; 2017 Jun; 42(6):6. PubMed ID: 28441161 [No Abstract] [Full Text] [Related]
19. Cannabis and Complex Posttraumatic Stress Disorder: A Narrative Review With Considerations of Benefits and Harms. Dagan Y; Yager J J Nerv Ment Dis; 2020 Aug; 208(8):619-627. PubMed ID: 32433200 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. Mizrachi Zer-Aviv T; Segev A; Akirav I Behav Pharmacol; 2016 Oct; 27(7):561-9. PubMed ID: 27551883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]